Authors : Ariba Javed; Junaid Tahseen; Nusrat Parveen; Bushra Aftab

Volume/Issue : Volume 11 - 2026, Issue 1 - January

Google Scholar : https://tinyurl.com/m8ndyf8j

Scribd : https://tinyurl.com/2y3asppa

DOI : https://doi.org/10.38124/ijisrt/26jan790

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Acne vulgaris is a prevalent chronic inflammatory disorder of the pilosebaceous unit, primarily affecting adolescents and young adults, with a notable impact on psychological and social well-being. In the Unani System of Medicine, this condition is identified as Buthūr Labaniyya and is attributed to disturbances in humoral equilibrium, particularly involving Fasād-i-Dam (vitiated blood), predominance of Balghām and Safrā, and increased intrinsic heat (Su’-e-Mizāj Ḥār). This review offers an integrative conceptual appraisal of acne vulgaris by correlating classical Unani principles with contemporary dermatological insights. Modern medicine explains acne pathogenesis through follicular hyperkeratinization, androgen-driven sebaceous hyperactivity, proliferation of Cutibacterium acnes, and subsequent inflammatory responses. In contrast, classical Unani scholars described the condition as a consequence of the accumulation of Mādda-e-Sadīdiyya and impaired elimination of morbid humours through the skin, particularly during adolescence. Therapeutic strategies in modern dermatology focus on topical and systemic agents targeting inflammation and sebum production, whereas Unani management emphasizes holistic interventions, including humoral purification (Tanqīya), dietary regulation (Ilāj bi’l- Ghidhā), regimenal therapies (Ilāj bi’l-Tadbīr), and herbal formulations. An integrative approach combining evidence-based modern therapies with Unani principles may enhance clinical outcomes, reduce recurrence, and promote long-term cutaneous and psychosocial health.

Keywords : Acne Vulgaris, Unani Medicine, Buthūr, Humoral Theory, Integrated Dermatology.

References :

1. Noor Kareem HKM. Akseer ul quloob tarjuma mufareh ul quloob. Munshi Nawal Kishore Publication (Lucknow); 1925:106-108.
2. Jain S, Barambhe M.S., Jain J, Jajoo U.N., Pandey N. Prevalence of Skin Diseases in Rural Central India. A Community Based, Cross-Sectional, Observational Study. Journal of Mahatma Gandhi Institute of Medical Sciences. September 2016; 21(2): 111-115.
3. Tan A.U., Schlosser B.J., Paller A.S. A review of diagnosis and treatment of acne in adult female patients. Int J women’s dermatology. 2018; 4:56–71. doi: 10.1016/j.ijwd.2017.10.006.
4. Quraishi Hasan Mohammad, et al., Jamiul Hikmat, volume 1 and volume 2. New Delhi Idara Kitab ul shifa: 2011:203,994-995.
5. Ibne sina Abu Ali, et al., Al Qanoon fit Tib (Urdu translation by Kantoori sayyed Gulam Husnain); Volume 4; New Delhi Idara Kitabul Shifa; YNM;1432.
6. Conforti C., Giuffrida R., Fadda S., Fai A., Romita P., Zalaudek I., Dianzani C. Topical dermocosmetics and acne vulgaris. Dermatol. Ther. 2021 doi: 10.1111/dth.14436.
7. Cui H., Feng C., Guo C., Duan Z. Development of novel topical anti-acne cream containing postbiotics for mild-to-moderate acne: an observational study to evaluate its efficacy. Indian J. Dermatol. 2022; 67:667–673. doi: 10.4103/ijd.ijd_655_22.
8. Layton A.M., Ravenscroft J. Adolescent acne vulgaris: current and emerging treatments. Lancet Child Adolesc Heal. 2023; 7:136–144. doi: 10.1016/S2352-4642(22)00314-5.
9. Almaseehi, Ibne Alqaf AFA. Kitabal Umda Fil jarahat. Vol.1. New Delhi: CCRUM; YNM:146.
10. Parveen H, Khan MA, Ahmad N. Acne Vulgaris (Busoor-e-Labaniya): Historical Insights, Unani Concepts, and Advances in Modern Treatment. World J Cosmetol Aesth Med, 2(1);01-05.
11. Tabri M. Moalejat e Buqratiyah. New Delhi: CCRUM; 1995:252.
12. N.Shah Siddarth et.al. API Text book of medicine. Volume: 2,8th Edition, Mumbai: The Association Physicians of India. 2008:1418-1420.
13. Kumar V. Abbas AK, Fausto N. Robbins & cortran Pathologic basis of disease. 7th Ed. Philadelphia: Sounders an Imprint of Elsevier, 2005: 1228-29,1264-65.
14. Sheema, Sidra, Naaz I. Pathophysiology of Buthuri-Labaniyya (Acne Vulgaris) in the Unani System of Medicine. J Biol Sci Opin. 2023;11(2):23-25.
15. Arzani MA. Mizanut-tib. 4th Ed. New delhi: Idara Kitabul Shifa; 2002: 249.
16. Khan A. Akseer Azam. Vol-4. Lucknow: Matab Munshi Naval Kishore; 1917: 450-1.
17. Behl PN,Aggarwal A, Srivastava G. Practice of Dermatology. 9th edition. New Delhi: CBS Publishers & Distributors; 2004: 408-41.
18. Sultana et al. Buthür-i-labaniyya (Acne vulgaris) With Special Reference to Unani Medicine: Review. Journal of AYUSH: 2015; 4(3): 1-6.
19. Ansari S. History of acne vulgaris and topical drugs in Unani medicine. Archives of Medicine and Health Sciences. 2019;7(2):293-7.
20. Khatoon F, Azahar M, Jabeen A, Uddin Q, Khan S, Moin MS et al., A comprehensive Review on Buthūr Labaniyya (Acne vulgaris) with special references of Unani System of Medicine. The Journal of Phytopharmacology 2021;10(6):468-477.
21. Sina I. In: Al-Qanoon. Hkm Ghulam Hussain Kantoori. Vol. 3. Lahore: Bashir and Sons; 1984. p. 161-3
22. Zouboulis CC, Katsambas AD, Kligman AM. Pathogenesis and Treatment of Acne and Rosaceae. US: Springer; 2014. p. 5-9.
23. Anjum S.  Concept of Busoor e Labaniya (Acne vulgaris) and its Management in Light of Unani System of Medicine. J Drug Deliv Ther. 2021; 1(5-S):159-163.
24. Jeelani Ghulam. Makhzane Hikmat. Vol.2. New Delhi: Ejaz Publication, 1996:689.
25. Hay RJ, et al. The Global Burden of Skin Disease in 2010. Journal of Investigative Dermatology. 2014;134(6):1527–1534.
26. Tan JK, Bhate K. A Global Perspective on the Epidemiology of Acne. British Journal of Dermatology. 2015;172(S1):3–12.
27. Eichenfield DZ, Sprague J, Eichenfield LF. Management of Acne Vulgaris: A Review. JAMA. 2021 Nov 23;326(20):2055-2067. DOI: 10.1001/jama.2021.17633.
28. Collier CN, et al. The Prevalence of Acne in Adults 20 Years and Older. Journal of the American Academy of Dermatology. 2008;58(1):56–59.
29. Sardana K, et al. Epidemiology of Acne Vulgaris: A Community-Based Study. Indian Journal of Dermatology. 2014;59(5):403–408.
30. Özçelik S, Kulaç İ, Yazıcı M, Öcal E. Distribution of childhood skin diseases according to age and gender, a single institution experience. Turk Pediatri Ars. 2018 Jun;53(2):105-112.
31. Kubba R, Bajaj A, Thappa D, Sharma R, Vedamurthy M, Dhar S. Epidemiology of acne. Indian Journal of Dermatology, Venereology, and Leprology 2009;75(7):3.
32. Motosko CC, Zakhem GA, Pomeranz MK, Hazen A. Acne: a side-effect of masculinizing hormonal therapy in transgender patients. Br J Dermatol. 2019 Jan;180(1):26-30.
33. http://www.nhp.gov.in/busoor-e-labaniya-acne-vulgaris%20.
34. Azmi AW, Moalijat.  (Amraz Jild  wa  Mutaalliqat-e-Jild).  New Delhi: Supreme Offset Press. 2000; IV: 144–46.
35. Yosipovitch G, Tang M, Dawn AG, Chen M, Goh CL, Huak Y, Seng LF. Study of psychological stress, sebum production and acne vulgaris in adolescents. Acta Derm Venereol. 2007;87(2):135-9.
36. Qarshi Hassan M. “Jami” al-Ḥikmat’ Vol-2. Delhi: Idārā Kitab al- Shifā Daryagunj; 2011. 1005.
37. Hakīm A khān. Ḥāziq. New Delhi: Ruby printing press; 1987: 550–52.
38. Azahar M et al.Therapeutic Evaluation of a Topical Unani Formulation, Tila-i  Muhāsāin  Buthūr  Labaniyya (Acne vulgaris):  A Randomised, Controlled Clinical Study.Cellmed.2020; 10(2)1-9.
39. Aleem S. Amraz-e-Jild. Aligarh. Saba Publishers. 2002; 74–78.
40. Vora S, Ovhal A, Jerajani H, Nair N, Chakrabortty A. Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne. Br J Dermatol. 2008 Sep;159(4):990-1.
41. Taylor M, Gomzalez M, R P.  Pathways to inflammation: Acne Pathophysiology. Eur J Dermatology. 2011; 21(3):323–33.
42. Kaisar Raza, Vaibhav Talwar AS and OPK. Acne: An understanding of the disease and its impact on life. Int J Drug Dev Res. 2012; 4(2):14–20.
43. Burns T, Breathnach S, Cox N, and Griffiths C. Rook's Textbook of Dermatology. 8th ed. Vol-I1. UK: Wiley Blackwell; 2010: 17-43,42.17-42.44.
44. Vora S, Ovhal A, Jerajani H, Nair N, Chakrabortty A.  Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne. Br J Dermatol. 2008; 159(4):990–1.
45. Baghdadi A.B.A. B.H. Kitabul Mukhtarat Fit-tib. Vol-IV. New Delhi: CCRUM; 2007: 188-189.
46. Chaudhary MK, Chaudhary M. A Review on Treatment Options for Acne Vulgaris. World Journal of Pharmacy and Pharmaceutical Sciences.2016;5(7):524-545.
47. Mohiuddin AK. A Comprehensive Review Antaki D. Tazkirah Oolil Albab (Arabic). Vol-II. New Delhi: CCRUM, Ministry of Health and Family Welfare; 2010: 87.
48. Jamal MA, Khan MR. Jild wa Tazeeniyat. New Delhi. Hidayat Publishers and Distributors; 2021:158-64.
49. Suva MA, Patel A M., Sharma N, Bhattacharya C, Mangi R K. A Brief Review on Acnе Vulgaris: Pathogenesis, Diagnosis and Treatment. Research & Reviews: Journal of Pharmacology. 2014; 4:1-12.
50. Knutsen-Larson S, Dawson AL, Dunnick CA, Dellavalle RP.  Acne vulgaris: Pathogenesis, Treatment, and Needs Assessment.  Dermatol Clin. 2012; 30(1):99–106.
51. Tom WL, Barrio VR.  New insights into adolescent Acne. Curr Opin Pediatr. 2008; 20:436–40.
52. Johnson JA, Kalia S, Wong J, Stein Gold L, Yu AM, Doiron PR, et al. The association between obesity and acne: a systematic review. Int J Dermatol. 2021;60(12):1490-9.
53. O'Neill AM, Gallo RL. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. Microbiome. 2018 Oct 02;6(1):177.
54. Vasam M., Korutla S, Bohara RA.Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology-based advances. Biochemistry and Biophysics Reports.2023 Nov 23;36:101578. doi: 10.1016/j.bbrep.2023.101578.
55. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ et al., Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. The Journal of Immunology 2002;169(3):1535–41.
56. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW. Tissue distribution and ontogeny of steroid 5a-reductaseisozyme expression. J Clin Invest. 1993;92(2):903-10.
57. Youn SW. The Role of Facial Sebum Secretion in Acne Pathogenesis: Facts and Controversies, Clin. Dermatol. 2010; 28: 8-11.
58. Alīm S. Amrāz-i Jild. Alighar: Ajmal Khan Tibbia College; 74.
59. Antāki D. Tadhkira Ūlī al-Albāb. Azhar J, editor. Egypt; YNM.39.
60. Arzānī MA. Mīzān al-Ṭib. Kabiruddin T by M, editor. New Delhi: Idārā Kitāb al-Shifā; 2001. 249.
61. Khān MĀ.  Iksīr-ī Āzam (Vol.  IV).  Lucknow:  Matba’ Nāmī, Munshī Nawal Kishor; 1917. 450-451,511-512.
62. Zakariyya AR.  al-Ḥāwi  Fi’l  Tibb (Vol.  23). M Y Siddiqui H, editor. Alighar: Saba Publishers Alighar, 1994: 36-37.
63. Ramli R., Malik A.S., Hani A.F.M., Jamil A. Acne analysis, grading and computational assessment methods: an overview. Skin Res. Technol.2012; 18:1–14. doi: 10.1111/j.1600-0846.2011.00542.
64. Khanna N. Illustrated Synopsis of Dermatology & Sexually Transmitted Diseases Edi. 4th. New Delhi. Elsevier India; 2011:110-20.
65. Gred Plewig AMK. Acne and Rosacea. 2nd ed. Springer-Verlag, Berg H, editors. Germany; 1993. 39–43.
66. Anitha S, Pakula LSN. Adolescent health care: A practical guide. 2002. 442-3.
67. Khanna N. Illustrated synopsis of dermatology and sexually transmitted diseases.  5^th editio.  New Delhi: RELX India Private Limited; 2017.305,309.
68. Ralston S, Penman ID, Strachan MWJ, Hobson RP, Britton R, Davidson S. Davidson’s principles and practice of medicine.2014: 1417.
69. Munjal Yp. API Textbook of Medicine. Vol.1. 9th Ed. Mumbai: The Association of Physicians of India; 2012: 507-509.
70. Kraft J, Freiman A Management of acne. CMAJ.2011. 183: E430-E435.
71. Jamal MA, Khan MR. Jild wa Tazeeniyat. New Delhi. Hidayat Publishers and Distributors; 2021:158-64.
72. Krowchuk DP, Stancin T, Keskinen R, Walker R, Bass J, Anglin TM. The psychosocial effects of acne on adolescents. Pediatr Dermatol. 1991;8(4):332–8.
73. Magin P, Adams J, Heading G, Pond D, Smith W. Psychological sequelae of acne vulgaris: results of a qualitative study. Can Fam Physician. 2006;52(8):978–9.
74. Dreno B, Bagatin E, Blume-Peytavi U, et al.  (2018) Female type of adult acne:  Physiological and psychological considerations and management. J Dtsch Dermatol Ges. 16: 1185-1194.
75. Bolognia JL, Schaffer JV, Cerroni L. Dermatology. Vol. 1. 4th ed. USA: Elseivier; 2018
76. Sutaria AH, Masood S, Saleh HM, Schlessinger J. acne vulgaris. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
77. Alsulaimani H, Kokandi A, Khawandanh S, Hamad R, Severity of Acne Vulgaris: Comparison of two assessment methods, Faculty of Medicine, King Abdulaziz of Sebum Composition initiate Acne Lesions. European Academy of Dermatology and Venereology. 2014; (28): 527-532.
78. Marquis J et al. Retinoic Acid in the treatment of acne.  Indian J Dermatology, Venereol Leprol. 1974:111(90):162–72.
79. William D James. Acne-Clinical Practice. N Engl J Med.  2005;14(352):1463–72.
80. Zohra FT, Sultana T, Islam S, Nasreen T, Evaluation of severity in patients of acne vulgaris by Global Acne Grading System in Bangladesh,2017 June 15.
81. Zaenglein, A. L., et al. (2016). "Guidelines of care for the management of acne vulgaris." Journal of the American Academy of Dermatology, 74(5), 945–973.e33.
82. Kataria U, Chhillar D. Acne: Etiopathogenesis and its management. Int Arch Integr Med Usha Kataria IAIM. 2015; 2(5):225–31.
83. Fox L., Csongradi C., Aucamp M., Du Plessis J., Gerber M. Treatment modalities for acne. Molecules. 2016; 21:1–20. doi: 10.3390/molecules21081063.
84. Baldwin H., Webster G., Stein Gold L., Callender V., Cook-Bolden F.E., Guenin E. 50 Years of topical retinoids for acne: evolution of treatment. Am. J. Clin. Dermatol. 2021 doi: 10.1007/s40257-021-00594-8.
85. Boonchaya P, Rojhirunsakool S, Kamanamool N, Khunkhet S, Yooyongsatit S, Udompataikul M. Minimum Contact Time of 1.25%, 2.5%, 5%, and 10% Benzoyl Peroxide for a Bactericidal Effect Against Cutibacterium acnes. Clin Cosmet Investig Dermatol. 2022; 15:403-9.
86. Eady EA, Jones CE, Tipper JL, Cove JH, Cunliffe WJ, Layton AM. Antibiotic resistant propioni bacteria in acne: Need for policies to modify antibiotic usage. BMJ. 1993;306(6877):555-6
87. Drake L, Reyes-Hadsall S, Barbieri JS, Mostaghimi A. New Developments in Topical Acne Therapy. Am J Clin Dermatol. 2022;23(2):125-136. doi: 10.1007/s40257-021-00666-9.
88. Chauhan PN, Sharma A, Rasheed H, Mathur H, Sharma P. Treatment Opportunities and Technological Progress Prospective for Acne Vulgaris. Curr Drug Deliv. 2023;20(8):1037-1048.
89. Lynde CW, Andriessen A. Cohort study on the treatment with dapsone 5% gel of mild to moderate inflammatory acne of the face in women. Skinmed. 2014;12(1):15-21.
90. Tzellos T., Zampeli V., Makrantonaki E., Zouboulis C.C. Treating acne with antibiotic-resistant bacterial colonization. Expet Opin. Pharmacother. 2011; 12:1233–1247. doi: 10.1517/14656566.2011.553192.
91. Lavers I. Diagnosis and management of acne vulgaris in aesthetic practice. J Aesthetic Nurs. 2014; 3:482–489.
92. Elsaie M.L. Hormonal treatment of acne vulgaris: an update. Clin. Cosmet. Invest. Dermatol. 2016 doi: 10.2147/CCID.S114830.
93. Ebede T.L., Arch E.L., Berson D. Hormonal treatment of acne in women. J Clin Aesthet Dermatol. 2009; 2:16–22.
94. Rashid B. ACNE VULGARIS IN PERSPECTIVE OF UNANI LITERATURE: A REVIEW. Journal of Biological & Scientific Opinion · Volume 6 (2). 2018.
95. Khan N. Acne Vulgaris (Busoore Labaniya) with research to Unani Medicine: Review. ParipexIndian Journal of Research 2020; 9(4):57-59.
96. CCRUM.  Anonymous. NFUM.  Part-1. Delhi:  Ministry of Health and Family Welfare, Govt. of India; 2006:96,124.
97. Khan A. Muhīṭ-i Āzam vol-2. New Delhi: CCRUM, Ministry of Health and Family Welfare; 2012. 385–388.
98. Razi A. Kitāb-al Fākhir Fit Tib. Part-1, Vol-1. New Delhi: Ministry of Health and Family Welfare India; c2005. p. 37-8, 28, 46.

99. Sheeraz, M, Topical effect of a novel formulation in Unani Medicine: Indian Journal of Research: Volume 7, May 2018.